Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

22.55USD
17 Jul 2019
Change (% chg)

$0.09 (+0.40%)
Prev Close
$22.46
Open
$22.39
Day's High
$22.59
Day's Low
$22.05
Volume
7,928
Avg. Vol
234,747
52-wk High
$22.75
52-wk Low
$8.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 2.63 -0.304
FY 2018 Dec '18 1.66 -0.248
Sep '18 1.03 -0.310
Jun '18 1.03 -0.370
Mar '18 1.03 -0.268
FY 2017 Dec '17 1.03 -0.286
Sep '17 1.03 -0.258
Jun '17 1.03 -0.233
Mar '17 1.03 -0.245
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 9 1.13 1.75 0.00 0.50
Quarter Ending Dec-19 9 1.12 1.75 0.00 0.50
Year Ending Dec-19 10 6.02 8.10 2.63 2.29
Year Ending Dec-20 9 6.72 20.31 1.14 27.18
Earnings (per share)
Quarter Ending Sep-19 11 -0.34 -0.19 -0.39 -0.29
Quarter Ending Dec-19 11 -0.35 -0.19 -0.40 -0.30
Year Ending Dec-19 11 -1.31 -0.86 -1.47 -1.16
Year Ending Dec-20 11 -1.33 -0.47 -1.68 -0.99
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 81.08 65.50 30.34
EPS (TTM) % 10.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Fate Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -3.45 39 --
13 Week 21.53 15.62 75 --
26 Week -0.48 -8.05 51 --
52 Week 38.72 17.58 73 --
YTD 64.14 44.15 79 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 98.82%
# of Holders: 174
Total Shares Held: 64,416,355
3 Mo. Net Change: 637,974
# New Positions: 7
# Closed Positions: 0
# Increased Positions: 12
# Reduced Positions: 6
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.